Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + PegIFN/RBV in Japanese HCV Genotype 1
NCT01017575Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Dec 2009; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01017575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017575.